GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-miR-140-3p.1
|
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_96811170 Show fit | 1.59 |
ENST00000288943.4
|
dual specificity phosphatase 2 |
|
chr10_+_11206925 Show fit | 1.40 |
ENST00000354440.2
ENST00000315874.4 ENST00000427450.1 |
CUGBP, Elav-like family member 2 |
|
chr3_-_18466787 Show fit | 1.35 |
ENST00000338745.6
ENST00000450898.1 |
SATB homeobox 1 |
|
chr16_+_50775948 Show fit | 1.03 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
cylindromatosis (turban tumor syndrome) |
|
chr19_+_19322758 Show fit | 0.92 |
ENST00000252575.6
|
neurocan |
|
chr2_-_136873735 Show fit | 0.92 |
ENST00000409817.1
|
chemokine (C-X-C motif) receptor 4 |
|
chr20_+_10199468 Show fit | 0.92 |
ENST00000254976.2
ENST00000304886.2 |
synaptosomal-associated protein, 25kDa |
|
chr1_-_65432171 Show fit | 0.90 |
ENST00000342505.4
|
Janus kinase 1 |
|
chr4_-_174320687 Show fit | 0.84 |
ENST00000296506.3
|
stimulator of chondrogenesis 1 |
|
chr17_+_38296576 Show fit | 0.78 |
ENST00000264645.7
|
cancer susceptibility candidate 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 1.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 1.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 1.0 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.2 | 0.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.9 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.1 | 0.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 1.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.0 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.8 | GO:0035500 | MH2 domain binding(GO:0035500) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.8 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |